Isoleucine infusion during "simulated" upper gastrointestinal bleeding improves liver and muscle protein synthesis in cirrhotic patients

Upper gastrointestinal (GI) bleeding in cirrhotic patients has a high incidence of mortality and morbidity. Postbleeding catabolism has been hypothesized to be partly due to the low biological value of hemoglobin, which lacks the essential amino acid isoleucine. The aims were to study the metabolic consequences of a "simulated" upper GI bleed in patients with cirrhosis of the liver and the effects of intravenous infusion of isoleucine. Portal drained viscera, liver, muscle, and kidney protein kinetics were quantified using a multicatheterization technique during routine portography. Sixteen overnight-fasted, metabolically stable patients who received an intragastric infusion of an amino acid solution mimicking hemoglobin every 4 hours were randomized to saline or isoleucine infusion and received a mixture of stable isotopes (L-[ring-2H5]phenylalanine, L-[ring-2H4]tyrosine, and L-[ring-2H2]tyrosine) to determine organ protein kinetics. This simulated bleed resulted in hypoisoleucinemia that was attenuated by isoleucine infusion. Isoleucine infusion during the bleed resulted in a positive net balance of phenylalanine across liver and muscle, whereas renal and portal drained viscera protein kinetics were unaffected. In the control group, no significant effect was shown.

CONCLUSION

The present study investigated hepatic and portal drained viscera protein metabolism selectively in humans. The data show that hepatic and muscle protein synthesis is stimulated by improving the amino acid composition of the upper GI bleed by simultaneous intravenous isoleucine administration.

[Compliance of the diet restricted with leucine, isoleucine and valine in maple syrup urine disease (MSUD) children]

The aim of this study was to evaluate the compliance of the diet with limited branched-chain amino acids (BCAA) content in long-term observation of patients with maple syrup urine disease (MSUD). The study group consisted of 7 children at age of 1.5-18 years. Nutrition evaluation was based on current diet records from 3-4 days, every 3-4 months. Energy and nutrition values of proposed daily products lists and diet records was compared with adequate references and recommendations. Energy and content of most of the nutrients in proposed daily products lists were in agreement with RDI except calcium. Diet analysis at MSUD children revealed insufficient contents of: iron, zinc, copper, vitamin B1, B2, niacin and vitamin C (often below 90% RDI).

Dietary branched-chain amino acid valine, isoleucine and leucine requirements of fingerling Indian major carp, Cirrhinus mrigala (Hamilton)

Three 8-week growth experiments were conducted to quantify the requirements of the fingerling Cirrhinus mrigala for the dietary branched-chain amino acids valine (experiment 1), isoleucine (experiment 2) and leucine (experiment 3). Six isonitrogenous (400 g/kg) and isoenergetic (17.90 kJ/g) test diets were formulated with a gradation of 2.5 g/kg for each test amino acid, valine (7.5-20 g/kg), isoleucine (5.0-17.5 g/kg) and leucine (7.5-20 g/kg), and fed to randomly stocked fish in circular troughs. In experiment 1, the maximum weight gain (312 %), best feed conversion ratio (FCR; 1.45) and best protein efficiency ratio (PER; 1.72) were obtained in fish fed 15.0 g dietary valine/kg. In experiment 2, the highest weight gain (317 %), best FCR (1.47) and best PER (1.70) were recorded at 12.5 g dietary isoleucine/kg, and in experiment 3, the highest weight gain (308 %), best FCR (1.46) and best PER (1.71) were noted at 15.0 g dietary leucine/kg. A quadratic regression analysis of weight gain, FCR and PER data showed an optimum requirement at 15.9, 15.0 and 14.8 g/kg for valine, 13.2, 12.3 and 12.1 g/kg for isoleucine and 15.6, 15.4 and 15.1 g/kg for leucine in dry diets. Low body moisture and higher protein were noted in fish fed diets containing 15.5, 12.5 and 15.0 g valine, isoleucine and leucine per kg, respectively. Body fat increased with increasing levels of the branched-chain amino acids. On the basis of a regression analysis of growth data, it is recommended that a diet for C. mrigala should contain valine at 15.2, isoleucine at 12.6 and leucine at 15.4 g/kg dry diet, corresponding to 38.0, 31.5 and 38.5 g/kg dietary protein, respectively.

Increasing dietary crude protein does not increase the essential amino acid requirements of kittens*

Essential amino acid (EAA) requirements of omnivores and herbivores (e.g. chicks, lambs, pigs and rats) are directly related to the concentration of dietary crude protein (CP). When an EAA is limiting in the diet, addition of a mixture of EAA lacking the limiting one (which increases dietary CP) results in a decrease in food intake and weight gain. This interaction has been referred to as an AA imbalance and has not been studied in depth in strict carnivores. The objectives of these experiments were to examine the effects on growing kittens (2-week periods) of the addition to diets of a mixture of AA lacking the limiting one. The control diets were at the requirement of the respective limiting EAA (or about 85% of the 1986 National Research Council requirement). In experiment 1, with the dietary EAAs at the minimally determined requirements, the concentration of the essential or dispensable amino acids was increased to determine if CP or an EAA was limiting. Results of growth rates (n = 12) and plasma AA concentrations indicated that tryptophan was limiting, but increased body weight gain also occurred when the concentration of CP was increased as dispensable amino acids without additional tryptophan. Experiment 1 was repeated in experiment 2 using a crossover design. Again, when tryptophan was limiting additional concentrations of dispensable AAs increased body weight gain. This response is the opposite of that in herbivores and omnivores. Experiment 3 consisted of 10 separate crossover trials, one for each of the 10 EAA and examined the effect of two concentrations of dietary CP (200 and 300 g CP/kg diet) on body weight gain of kittens (n = 8) offered diets limiting in each respective EAA. Body weight gain was numerically greater when diets contained 300 g CP/kg than 200 g CP/kg for eight of 10 EAAs (p < 0.05 for only isoleucine and threonine) when each amino acid was limiting. This response is the reverse of that which occurs in chicks, lambs, pigs and rats when an EAA is limiting and dietary CP lacking the limiting EAA is increased. These results indicate that the EAA requirements of kittens are not positively correlated with dietary CP concentrations.

4-Hydroxyisoleucine an unusual amino acid as antidyslipidemic and antihyperglycemic agent

Trigonella foenum-graecum, commonly known as fenugreek, is an annual herbaceous plant. From the seeds of T. foenum-graecum an unusual amino acid, 4-hydroxyisoleucine 5, has been isolated, which significantly decreased the plasma triglyceride levels by 33% (P<0.002), total cholesterol (TC) by 22% (P<0.02), and free fatty acids by 14%, accompanied by an increase in HDL-C/TC ratio by 39% in the dyslipidemic hamster model.

Short Communication: Amino Acids Antagonistic to the Amino Acids Inhibitory for Growth Rate of Mixed Ruminal Bacteria

Antagonism of some amino acids (AA) to the inhibitory effects of other AA (Ile, Phe, and Thr) on the growth rate of mixed ruminal bacteria was investigated. In vitro growth rate of the mixed ruminal bacteria was inhibited when the 3 inhibitory AA (1 mM each) were each added to individual control treatments in which an ammonium salt was included as a sole N source. The inhibitory effect caused by Ile was relieved by addition of Leu or Val (equimolar to Ile), and no significant inhibition was shown when both Leu and Val were added together with Ile. The growth inhibition caused by Phe was also alleviated by supplementing with Trp, and was completely negated by adding Tyr. The inhibitory effect of Thr, on the other hand, was not affected by addition of Lys or Met (which are synthesized using a common pathway with Thr), but was mitigated by supplementation with Glu, Ser, Val, Ala, or Gln. Among the antagonistic AA, Leu, Val, Trp, Tyr, and Glu were indispensable for the maximum growth rate of the ruminal bacteria under the experimental condition of supplementation of amino-N, the removal of which from a mixture of 20 protein AA caused the growth rate to decline. Removals of Ile along with Leu or Val or both, of Phe along with Trp or Tyr, and of Thr along with Glu recovered the promotion of bacterial growth rate. It was concluded that inhibitions of the bacterial growth rate caused by Ile, Phe, or Thr could be antagonized by some other AA (Leu, Val, Tyr, Trp, or Glu), and the role of these latter AA as relievers of the inhibitory effects could explain why they are indispensable for maximum growth rate of ruminal bacteria.

Branched-chain amino acids improve glucose metabolism in rats with liver cirrhosis

It is well established that impaired glucose metabolism is a frequent complication in patients with hepatic cirrhosis. We previously showed that leucine, one of the branched-chain amino acids (BCAA), promotes glucose uptake under insulin-free conditions in isolated skeletal muscle from normal rats. The aim of the present study was to evaluate the effects of BCAA on glucose metabolism in a rat model of CCl(4)-induced cirrhosis (CCl(4) rats). Oral glucose tolerance tests were performed on BCAA-treated CCl(4) rats. In the CCl(4) rats, treatment with leucine or isoleucine, but not valine, improved glucose tolerance significantly, with the effect of isoleucine being greater than the effect of leucine. Glucose uptake experiments using isolated soleus muscle from the CCl(4) rats revealed that leucine and isoleucine, but not valine, promoted glucose uptake under insulin-free conditions. To clarify the mechanism of the blood glucose-lowering effects of BCAA, we collected soleus muscles from BCAA-treated CCl(4) rats with or without a glucose load. These samples were used to determine the subcellular location of glucose transporter proteins and glycogen synthase (GS) activity. Oral administration of leucine or isoleucine without a glucose load induced GLUT4 and GLUT1 translocation to the plasma membrane. GS activity was augmented only in leucine-treated rats and was completely inhibited by rapamycin, an inhibitor of mammalian target of rapamycin. In summary, we found that leucine and isoleucine improved glucose metabolism in CCl(4) rats by promoting glucose uptake in skeletal muscle. This effect occurred as a result of upregulation of GLUT4 and GLUT1 and also by mammalian target of rapamycin-dependent activation of GS in skeletal muscle. From these results, we consider that BCAA treatment may have beneficial effects on glucose metabolism in cirrhotic patients.

Effects of branched-chain amino acids on DNA synthesis and proliferation in primary cultures of adult rat hepatocytes

We investigated the effects of branched-chain amino acids on DNA synthesis and proliferation in primary cultures of adult rat hepatocytes. Of the branched-chain amino acids, only leucine (10(-5)-10(-3) M) induced hepatocyte DNA synthesis and proliferation in a time- and dose-dependent manner. The addition of valine or isoleucine on its own had no significant effects on the hepatocyte DNA synthesis and proliferation. When combined, isoleucine competitively antagonized leucine-stimulated hepatocyte mitogenesis. U73122 (10(-6) M), AG1478 (10(-7) M), wortmannin (10(-7) M), PD98059 (10(-6) M) and rapamycin (10 ng/ml) inhibited the ability of leucine to stimulate the hepatocyte DNA synthesis and proliferation, suggesting that phospholipase C, tyrosine kinase, phosphatidylinositol 3-kinase, mitogen-activated protein (MAP) kinase, and p70 S6 kinase are involved in leucine signaling. The mitogenic effects of leucine are completely abolished by the addition of anti-transforming growth factor-alpha (TGF-alpha) antibody to the culture medium. Furthermore, leucine stimulated TGF-alpha secretion into the culture medium and the leucine effect was inhibited by U73122. Isoleucine alone had no significant effect on TGF-alpha secretion but this agent blocked leucine-induced TGF-alpha secretion. The results suggest that leucine triggers TGF-alpha secretion through a putative leucine receptor. The secreted TGF-alpha then stimulates hepatocyte DNA synthesis and proliferation through activation of TGF-alpha receptor to induce tyrosine kinase/MAP kinase activity and other downstream growth-related signal transducers.

Isoleucine needs of thirty- to forty-day-old female chickens: immunity

Broilers fed diets with reduced amino acid levels may be limiting in isoleucine. Because research addressing daily Ile needs for broiler immunity is sparse, Ile responses for immunity in female broilers were evaluated in 2 experiments in broilers from 30 to 42 d of age. Cellular and humoral immunity were evaluated in diets limiting in Ile and diets varying in Ile from deficient to adequate. Pen was the experimental unit in both experiments. Treatments in experiment 1 consisted of 2 levels of Ile (0.42 vs. 0.72% total of diet) and 3 strains of broilers, Arbor Acres+, Ross 508, Ross 708 (6 treatments; 5 pens each). In experiment 1, measurements consisted of: a cutaneous basophil hypersensitivity test to phytohemagglutinin-P (PHA-P) on d 37 and 38; cell quantification of CD4+, CD8+, and BU-1+ lymphocytes at d 41 and 42; and relative immune organ weights at 42 d. No Ile x strain interaction occurred. Feeding an Ile-deficient diet to broilers suppressed the cell mediated response to PHA-P, and reduced thymus weight and the percentage of CD8+ T cells. There were no significant differences between strains. In experiment 2, gradations of Ile (0.42, 0.50, 0.58, 0.66, 0.74, and 0.82% total of diet) were fed to one strain (Ross 508) of female broilers (7 pens per diet). A control diet containing 0.70% Ile (6 pens) was compared with an Ile surfeit concentration. Measurements in experiment 2 consisted of a hypersensitivity test to PHA-P on d 35 and 36; a primary antibody response to SRBC from 35 to 42 d; cell quantification of CD8+ alpha, beta, and T cell receptor (TCR)-1 (delta/gamma) lymphocytes on d 41 and 42; and immune organ weights at 42 d. Immunity measurements in birds fed surfeit Ile in the titration diets were equal to birds fed the control diet. A linear response to increasing Ile was obtained for relative bursa, but no Ile quadratic responses were noted for other measurements in experiment 2. Although feeding broilers a diet deficient in Ile suppressed some immune criteria, it does not appear that a marginal Ile deficiency will compromise immunity in growing female broilers.

Isoleucine needs of thirty- to forty-two-day-old female chickens: growth and carcass responses

Two experiments were conducted to evaluate Ile responses in female broilers. In experiment 1, dietary Ile was 0.42 or 0.72% total of diet. Diets were fed to 3 broiler strains: multipurpose Arbor Acres+, high-yield Ross 508, and high-yield Ross 708. In experiment 2, dietary Ile dose responses (0.42 to 0.82% total of diet in 0.08% increments) were evaluated. A corn-soybean meal control (0.70%) diet was used in experiment 2 (6 replications). No Ile x strain interactions occurred. Feeding broilers 0.42% Ile suppressed (P < 0.05) BW gain, feed intake, feed conversion, and breast and thigh yields. Arbor Acres+ strain had a higher BW gain and feed intake (P < 0.05) than the Ross 508 and 708 strains. Differences (P < 0.05) among strains were observed in breast and drumstick yields; Ross 708 broilers had increased breast and drumstick yields in comparison to birds from the Arbor Acres+ and Ross 508 strains. Birds fed surfeit Ile in the titration diets grew as well as (P < 0.05) the birds fed the control diet. Quadratic responses (P < 0.05; 95% of response) were obtained for BW gain (0.67%), feed intake (0.66%), feed conversion (0.68%), and breast meat yield (0.63%). The 30- to 42-d Ile need for female broilers is between 0.63 and 0.68% of total diet (0.59 to 0.64% digestible Ile).

Increased cytotoxicity of soluble Fas ligand by fusing isoleucine zipper motif

Fas (CD95) ligand (FasL) has the ability to induce apoptosis in Fas-expressing glioma cells by binding to Fas. Several molecular species have been designed to be soluble Fas ligands for therapeutic purposes. We successfully constructed a chimeric soluble FasL by fusing an isoleucine zipper motif for self-oligomerization and a FLAG sequence to the extracellular domain of the human Fas ligand (FIZ-shFasL). The cytotoxic effect of FIZ-shFasL on Jurkat cells was equivalent to that of membrane-bound FasL and approximately 10-fold stronger than that of agonistic anti-Fas antibody (CH-11). Flow cytometric analysis demonstrated that the differential Fas expression of human brain tumor cell lines partially correlated with levels of apoptosis through FIZ-shFasL. The upper limit of FIZ-shFasL for safe systemic administration to rat is estimated as below 2 microg/ml in plasma concentration. FIZ-shFasL could be applicable as a therapeutic agent for cancer.

Treatment with leucine stimulates the production of hepatocyte growth factor in vivo

Hepatocyte growth factor (HGF) has pleiotropic effects. Up-regulation of HGF activity in vivo may be beneficial. Branched-chain amino acids (BCAAs) are known to modulate various cellular functions. When starved rats received intraperitoneal injections of valine, leucine or isoleucine, only leucine treatment increased both hepatic and circulating levels of HGF in a dose-dependent manner, up to 1.5 and 2.3 times higher, respectively, than in controls. When young growing rats with free access to food were injected with leucine once a day for a week, HGF levels and liver weights were significantly higher than those of control rats. Furthermore, 1 week of leucine treatment of adult rats resulted in elevated serum albumin levels with an increase in HGF levels. Taken together with our previous report showing that leucine stimulates HGF production by hepatic stellate cells in culture, leucine, among BCAAs, may induce an increase in HGF production by the liver in vivo.

Utilization of spray-dried blood cells and crystalline isoleucine in nursery pig diets1

Three experiments were conducted to evaluate spray-dried blood cells (SDBC) and crystalline isoleucine in nursery pigs. In Exp. 1, 120 pigs were used to evaluate 0, 2, 4, and 6% SDBC (as-fed basis) in a sorghum-based diet. There were six replicates of each treatment and five pigs per pen, with treatments imposed at an initial BW of 9.3 kg and continued for 16 d. Increasing SDBC from 0 to 4% had no effect on ADG, ADFI, and G:F. Pigs fed the 6% SDBC diet had decreased ADG (P < 0.01) and G:F (P = 0.06) compared with pigs fed diets containing 0, 2, or 4% SDBC. In Exp. 2, 936 pigs were used to test diets containing 2.5 or 5% SDBC (as-fed basis) vs. two control diets. There were six replicates of each treatment at industry (20 pigs per pen) and university (six pigs per pen) locations. Treatments were imposed at an initial BW of 5.9 and 8.1 kg at the industry and the university locations, respectively, and continued for 16 d. Little effect on pig performance was noted by supplementing 2.5% SDBC, with or without crystalline Ile, in nursery diets. Pigs fed the 5% SDBC diet without crystalline Ile had decreased ADG (P < 0.01), ADFI (P < or = 0.10), and G:F (P < 0.05) compared with pigs fed the control diets. Supplementation of Ile restored ADG, ADFI, and G:F to levels that were not different from that of pigs fed the control diets. In Exp. 3, 1,050 pigs were used to test diets containing 5, 7.5, or 9% SDBC (as-fed basis) vs. a control diet. There were six replicates of each treatment at the industry (20 pigs per pen) location and five replicates at the university (six pigs per pen) locations. Treatments were imposed at an initial BW of 6.3 and 7.0 kg at the industry and university locations, respectively, and continued for 16 d. Supplementation of 5% SDBC without crystalline Ile decreased ADG and G:F (P < 0.01) compared with pigs fed the control diet, but addition of Ile increased ADG (P < 0.01) to a level not different from that of pigs fed the control diet. The decreased ADG, ADFI, and G:F noted in pigs fed the 7.5% SDBC diet was improved by addition of Ile (P < 0.01), such that ADG and ADFI did not differ from those of pigs fed the control diet. Pigs fed diets containing 9.5% SDBC exhibited decreased ADG, ADFI, and G:F (P < 0.01), all of which were improved by Ile addition (P < 0.01); however, ADG (P < 0.05) and G:F (P = 0.09) remained lower than for pigs fed the control diet. These data indicate that SDBC can be supplemented at relatively high levels to nursery diets, provided that Ile requirements are met.

Isoleucine requirements and ratios in starting (7 to 11 kg) pigs1

Two experiments were conducted to refine the Ile needs in 7- to 11-kg pigs. In Exp. 1, 1,680 pigs were fed a 1.25% digestible Lys diet containing 7.5% spray-dried blood cells (as-fed basis) with supplemental crystalline Ile (0.06% increments) to generate seven levels of apparent digestible Ile (0.47 to 0.83%). There were 12 replicates of each treatment with 20 pigs per pen, and treatments were imposed at an initial BW of 7 kg and continued for 16 d. Responses in ADG, ADFI, G:F, and plasma urea nitrogen (PUN) were quadratic (P < 0.01) over the 16-d period. Data were fitted to both a single-slope broken line and a quadratic fit, and when the quadratic response curve was superimposed on the broken line, the points at which the quadratic curve first intersected the plateau of the broken line occurred at 0.70, 0.73, 0.66, and 0.65% digestible Ile for ADG, ADFI, G:F, and PUN, respectively. Using the ADG and ADFI obtained at this intersection point resulted in an estimate of 9.1 mg of digestible Ile per gram of weight gain. In Exp. 2, 1,840 pigs were fed similarly composed diets, except that digestible Lys was lowered in six diets to 1.10% by decreasing soybean meal. Crystalline Ile was supplemented at 0.09% increments to generate six levels of digestible Ile (0.37 to 0.83%). A seventh diet contained 1.25% digestible Lys by supplementing the 0.83% digestible Ile diet with 0.19% L-Lys HCl to verify that 1.10% digestible Lys was deficient for these pigs. There were 12 replicates of each treatment with 22 pigs per pen, and treatments imposed at an initial BW of 7 kg and continued for 16 d. Supplementation of Lys to the 0.83% digestible Ile diet (1.10 vs. 1.25% digestible Lys) did not affect ADG (260 vs. 264 g/d, P = 0.60) and ADFI (359 vs. 343 g/d, P = 0.20), whereas G:F (725 vs. 774 g/kg, P < 0.01) was improved by increasing dietary Lys. Responses in ADG, ADFI, and G:F to the first six diets were quadratic (P < 0.01) over the 16-d period. The points at which the quadratic curve first intersected the plateau of the broken line occurred at 0.686, 0.638, and 0.684% digestible Ile for ADG, ADFI, and G:F, respectively. Using the ADG and ADFI obtained at this intersection point results in an estimate of 9.9 mg of digestible Ile per gram of weight gain. These results suggest that although the percent digestible Ile requirement and digestible Ile:Lys ratio for starter (7 to 11 kg) pigs may be higher than 1998 NRC recommendations, the requirement may be lower than current recommendations when taking gain and feed intake into account.

The role of methionine in ethylmalonic encephalopathy with petechiae

BACKGROUND

Among patients with ethylmalonic aciduria, a subgroup with encephalopathy, petechial skin lesions, and often death in infancy is distinct from those with short-chain acyl-coenzyme A dehydrogenase deficiency or multiple acyl-coenzyme A dehydrogenase deficiency. The nature of the molecular defect in this subgroup is unknown, and the source of the ethylmalonic acid has been unclear.

OBJECTIVE

To determine whether the administration of candidate amino acids increased the excretion of ethylmalonic acid.

DESIGN

Examination of patterns of organic acids excreted in the urine before and following loading doses of isoleucine and methionine.

SETTING

General clinical research center.

PATIENT

An infant with ethylmalonic aciduria, global developmental delay, acrocyanosis, and intermittent showers of petechiae.

MAIN OUTCOME MEASURE

Excretion of ethylmalonic acid in the urine.

RESULTS

Loading with methionine increased the excretion of ethylmalonic acid, whereas loading with isoleucine did not. Restriction of the dietary intake of methionine decreased ethylmalonic acid excretion.

CONCLUSION

In ethylmalonic acid encephalopathy with petechiae, methionine is a precursor of ethylmalonic acid.

Isoleucine requirement for late-finishing (87 to 100 kg) pigs1

Three pig trials were carried out to determine the true digestible Ile requirement for maximal weight gain and minimal plasma urea nitrogen (PUN) of late-finishing (87 to 105 kg) pigs. In Exp. 1, an Ile-deficient basal diet was developed and confirmed to be markedly deficient in Ile, yet fully efficacious when fortified with surfeit Ile. This diet contained corn and dried red blood cells (RBC) as Ile sources, and was analyzed to contain 10.5% CP, 0.25% Ile, and 0.63% lysine; ME was calculated to be 3,475 kcal/kg. True digestibility of Ile in the basal diet was 88% based on previous digestibility trials in ileal-cannulated pigs and cecectomized roosters. Experiment 2 was a growth trial that involved five graded levels of crystalline Ile supplementation (0.02%) to generate five dose levels of true digestible Ile (0.25 to 0.33%), Diets 1 through 5, respectively. Gain and feed efficiency showed a linear response to incremental doses of Ile (P = 0.003 and 0.036, respectively), with an apparent plateau at 0.31% true digestible Ile. In Exp. 3, a replicated 5 x 5 Latin square, five barrows (Square 1) and five gilts (Square 2) were used in five 4-d feeding periods, with five levels of true digestible Ile (0.22 to 0.30%). Using feed intake as a covariate, a linear decrease in PUN occurred in gilts (8.9, 8.6, 8.0, 7.0, and 5.5; P = 0.004) and in gilts and barrows combined (9.5, 9.2, 9.2, 8.5, and 7.6; P = 0.006) as Ile increased incrementally. The PUN results for barrows (10.5, 10.0, 10.2, 9.9, and 9.7) were not affected by dietary Ile (P = 0.417). The results of these experiments suggest that the factorial requirement estimate of 0.30% true digestible Ile for high-lean, late-finishing pigs suggested by the NRC Subcommittee on Swine Nutrition is accurate.

Isoleucine, a potent plasma glucose-lowering amino acid, stimulates glucose uptake in C2C12 myotubes

To examine which branched-chain amino acids affect the plasma glucose levels, we investigated the effects of leucine, isoleucine, and valine (0.3 g/kg body weight p.o.) in normal rats using the oral glucose tolerance test (OGTT, 2 g/kg). A single oral administration of isoleucine significantly reduced plasma glucose levels 30 and 60 min after the glucose bolus, whereas administration of leucine and valine did not produce a significant decrease. Oral administration of valine significantly enhanced the plasma glucose level at 30 min after the glucose administration and leucine had a similar effect at 120 min. At each measurement timepoint, the insulin levels of the treated groups were lower than that of the control group. We then investigated the effects of leucine, isoleucine or valine at the same concentration (1 mM) on glucose metabolism in C(2)C(12) myotubes in the absence of insulin. Glucose consumption was elevated by 16.8% in the presence of 1 mM isoleucine compared with the control. Conversely, 1 mM leucine or valine caused no significant changes in glucose consumption in the C(2)C(12) myotubes. The 2-deoxyglucose uptake of C(2)C(12) myotubes significantly increased upon exposure to 1-10 mM isoleucine and 5-10 mM leucine. However, isoleucine caused no significant difference in glycogen synthesis in C(2)C(12) myotubes, although leucine and valine caused a significant increase in intracellular glycogen compared with the control. The isoleucine effect on glucose uptake was mediated by phosphatidylinositol 3-kinase (PI3K), but was independent of mammalian target of rapamycin (mTOR). These results suggest that isoleucine stimulates the insulin-independent glucose uptake in skeletal muscle cells, which may contribute to the plasma glucose-lowering effect of isoleucine in normal rats.

Dietary isoleucine responses in male broiler chickens

1. Three experiments were conducted to measure growth and carcase responses of growing and finishing broilers fed on test diets formulated to be deficient in isoleucine (Ile). 2. Dose titration methodology was used to measure growth and carcase responses of growing and finishing broilers to graduations of Ile in three additional experiments. 3. The experiments were conducted from d 18 to 30, 30 to 42, and 42 to 56. 4. Broilers given Ile-deficient test diets had poorer weight gain, feed conversion and carcase responses than broilers fed on Ile test diets containing a surfeit of Ile. Adding supplemental Ile to the test diet resulted in equivalent growth and carcase responses to those of broilers fed on the control diet with equal Ile from intact protein sources. 5. Recommended total Ile needs varied between 6.7 and 7.1 g/kg from d 18 to 30, 6.4 to 6.6 g/kg from d 30 to 42, and 5.5 to 6.6 g/kg from d 42 to 56.

Parenteral and enteral routes of feeding in neonatal piglets require different ratios of branched-chain amino acids

The requirements for total branched-chain amino acids (BCAA), isoleucine, leucine and valine, in neonatal piglets receiving parenteral and enteral nutrition was determined recently. The optimum ratio among BCAA during different routes of feeding is not yet known. In this study, the ratio of BCAA during parenteral and enteral feeding was tested using the indicator amino acid oxidation (IAAO) technique. Male Yorkshire piglets (n=24) received amino acid-based diets containing adequate nutrients for 5 d. Phenylalanine oxidation and kinetics were determined from a 4-h primed, constant infusion of L-[1-14C]-phenylalanine on d 6 and 8. On d 6, all piglets received a BCAA diet which met 75% of the total BCAA requirement, based on our previous research, with a ratio of 1:1.8:1.2 of isoleucine/leucine/valine. On d 8, the piglets were randomly assigned to receive one of the 3 test diets supplemented with isoleucine (+isoleucine), leucine (+leucine) or valine (+valine) to meet 100% of requirement, with the remaining two BCAA at 75% of requirement. The difference in phenylalanine oxidation (% of dose) between d 6 and 8 was used as an indicator of BCAA adequacy. In enterally fed piglets, the change in the percentage of the dose oxidized was minimal for all 3 test diets (mean=1.15%). In parenterally fed piglets, the difference in phenylalanine oxidation (% of dose) between d 6 and 8 was +isoleucine (12.6%), +leucine (2%) and +valine (6.6%). The ratio of 1:1.8:1.2 of isoleucine/leucine/valine is appropriate for enteral feeding, but during parenteral feeding, isoleucine was first limiting and valine was second limiting.

Requirement of tryptophan in relation to the supply of large neutral amino acids in laying hens

The present study was undertaken to find out whether the tryptophan requirement of laying hens is influenced by the supply of large neutral amino acids (LNAA). A factorial experiment was performed in which the dietary tryptophan concentration was varied at six different levels (1.0, 1.25, 1.5, 1.75, 2.0, and 2.5 g tryptophan/kg diet). As the second factor, the dietary concentrations of LNAA (isoleucine, valine, leucine, phenylalanine, and tyrosine) were varied at two levels. The first level provided an adequate supply of these amino acids; at the second level the concentrations of these amino acids were 40% higher than at the first level. The tryptophan requirement was estimated by a broken-line model and an exponential model of regression analysis. The tryptophan intake required for optimum (100% of maximum in the broken-line model, 95% of the maximum in the exponential model) egg production and daily egg mass was lower in hens fed the diets with high LNAA concentrations (145 and 155 mg/hen per day, respectively, in average of both models) than in hens fed the diets with adequate concentrations of LNAA (184 and 198 mg/hen per day, respectively, in average of both models). In contrast, the tryptophan requirement for optimum BW gain was lower in hens fed the diets with adequate LNAA concentrations (178 mg tryptophan per day) than in hens fed the diets with a high concentration of LNAA (212 mg tryptophan per day). In conclusion, the study suggests that an interaction between dietary LNAA and tryptophan exists in laying hens.

Isoleucine requirement of growing (25 to 45 kg) pigs

Three pig bioassays and two digestibility trials were conducted to determine the true digestible Ile requirement for maximal weight gain and minimal plasma urea nitrogen (PUN) of growing (25 to 45 kg) pigs. In Exp. 1, an Ile-deficient basal diet was developed and confirmed to be markedly deficient in Ile, yet fully efficacious when fortified with surfeit Ile. This diet contained corn, red blood cells, and soybean meal as Ile sources, and was analyzed to contain 15.5% crude protein, 0.34% Ile, and 0.95% lysine; metabolizable energy was calculated to be 3,430 kcal/kg. True digestibility of Ile in the basal diet was 89% based on digestibility trials in ileal-cannulated pigs and cecectomized roosters. The first growth trial (Exp. 2) involved six dose levels of true digestible Ile (0.38 to 0.58%), which resulted in a quadratic (P < 0.02) response in weight gain by growing pigs over a 21-d period. The weight-gain data were fitted to both a single-slope broken line and a quadratic fit, and when the quadratic response curve was superimposed on the broken line, the point at which the quadratic curve first intersected the plateau of the broken line occurred at 0.50% true digestible Ile. This (objective) requirement estimate was similar to that determined by taking 90% of the upper asymptote of the quadratic fitted line. In Exp. 3, a replicated 5 x 5 Latin square, five barrows (square 1) and five gilts (square 2) together with five 4-d feeding periods and five levels of true digestible Ile were utilized. A linear (P < 0.01) decrease in PUN occurred as Ile was incremented, with an apparent plateau occurring at 0.50% true digestible Ile. The results of these experiments suggest that the true digestible Ile requirement of grower (25 to 45 kg) pigs is 0.50% of the diet, or 1.46 g/Mcal of metabolizable energy, somewhat higher than the 1.38 g/Mcal metabolizable energy estimated by the 1998 National Research Council Subcommittee on Swine Nutrition.

Effects of a branched-chain amino acid drink in mania

BACKGROUND

Administration of a complex tyrosine-free amino acid drink acutely decreases manic symptoms. Although a nutrient-based approach to illness management is attractive, complex amino acid drinks are too unpalatable for repeated administration.

AIMS

To assess whether a simple, branched-chain amino acid (BCAA) drink diminishes manic symptoms acutely and following repeated administration.

METHOD

Twenty-five patients with mania were randomly and blindly allocated to treatment with BCAA (60 g) or placebo daily for 7 days.

RESULTS

Relative to placebo, the BCAA drink lowered mania ratings acutely over the first 6 h of treatment. In protocol completers there was a persistent advantage to the BCAA group 1 week after the end of treatment.

CONCLUSIONS

A nutritional intervention that decreases tyrosine availability to the brain acutely ameliorates manic symptoms. Further studies are required to assess whether this approach has longer-term efficacy.

Interactions of various supplies of isoleucine, valine, leucine and tryptophan on the performance of laying hens

The present study was undertaken to investigate the interactions among the supplies of isoleucine, leucine, valine, and tryptophan in laying hens. A three-factor trial was conducted with laying hens in which the dietary concentrations of isoleucine (5.7, 8.0, and 11.5 g/kg), valine and leucine (6.3 and 7.2 g/kg and 10.1 and 11.5 g/kg, respectively), and tryptophan (1.5 and 2.4 g/kg) were varied. At the lowest concentration of valine + leucine, an increase in dietary isoleucine concentration led to a dose-dependent reduction in feed consumption, daily egg mass, and body weight gain and an increase of the isoleucine concentration in plasma. At a high dietary concentration of valine + leucine, excess dietary isoleucine concentration caused only a weak depression of performance parameters; the isoleucine concentration in plasma was independent of the dietary isoleucine concentration. Increasing the dietary tryptophan concentration did not influence the effect of an excessive dietary isoleucine concentration on performance parameters. Increasing the tryptophan concentration from 1.5 to 2.4 g/kg diet did, however, lead to a significant increase in feed consumption, irrespective of the supply of isoleucine, valine, and leucine. In conclusion, our study demonstrates that the supply of valine + leucine influenced the effects of excess dietary isoleucine in laying hens, whereas the supply with tryptophan did not.

New legume sources as therapeutic agents

This review evaluates the potential health benefits of three legume sources that rarely appear in Western diets and are often overlooked as functional foods. Fenugreek (Trigonella foenum graecum) and isolated fenugreek fractions have been shown to act as hypoglycaemic and hypocholesterolaemic agents in both animal and human studies. The unique dietary fibre composition and high saponin content in fenugreek appears to be responsible for these therapeutic properties. Faba beans (Vicia faba) have lipid-lowering effects and may also be a good source of antioxidants and chemopreventive factors. Mung beans (Phaseolus aureus, Vigna radiatus) are thought to be beneficial as an antidiabetic, low glycaemic index food, rich in antioxidants. Evidence suggests that these three novel sources of legumes may provide health benefits when included in the daily diet.

Re-evaluation of the isoleucine requirement of the commercial layer

An experiment was conducted with Hy-Line W36 hens to re-evaluate their Ile requirements from a corn-soybean meal diet. Eight experimental diets were fed with Ile levels of 0.60, 0.57, 0.54, 0.51, 0.48, 0.45, 0.42, and 0.39%. Supplemental amino acids (AA) were added to ensure that ILe was the first-limiting AA. Increasing levels of Ile above 0.51% significantly increased egg production (EP), egg weight (EW), and egg mass (EM). Egg production, EW, and EM decreased each time the Ile content of the diet was decreased. Feed consumption (FC) and energy intake were not significantly decreased until the diet contained 0.45% Ile, and, at this time, BW was significantly reduced. Broken-line regression indicated a daily Ile requirement of 449.8, 497.0, and 469.0 mg/d for EP, EW, and EM, respectively, which indicated a requirement of 9.30 mg Ile/g EM.